GlassScriptPhysician profile
Paul A Cournoyer
NPI 1609819234
$1,314.94
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2021: $123 · 2022: $155 · 2024: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $319.11 | 2019-2022 | |
| Fusion Orthopedics USA, LLC | $251.39 | 2024 | |
| Wright Medical Technology, INC. | $131.38 | 2019 | |
| Convatec INC. | $130.06 | 2024 | |
| Integra Lifesciences Corporation | $99.18 | 2019 | |
| Misonix INC | $98.47 | 2021 | |
| Zimmer Biomet Holdings, INC. | $88.23 | 2019 | |
| Smith+Nephew, INC. | $58.32 | 2019-2022 | |
| Orthofix Medical, INC. | $24.91 | 2021 | |
| Advanced Oxygen Therapy INC. | $22.71 | 2024 | Topical Oxygen Chamber For Extremities |
| Novo Nordisk INC | $18.18 | 2022 | |
| Medartis INC. | $18.16 | 2019 | |
| Merck Sharp & Dohme LLC | $15.67 | 2019 | |
| Mimedx Group, INC. | $14.06 | 2024 | |
| Acumed LLC | $13.50 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Cournoyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.